meerkat,3M control 80% of transdermal drug sales in USA.That is...

meerkat,
3M control 80% of transdermal drug sales in USA.That is worth around $13,000,000,000 est by end of 2010.So 80% of that is there estimated turnover.
the vaccine market is worth Half a trillion and growing.
OBJ can get into this because it has been proved to be successful with vaccines.
the market is worth $500,000,000,000,000.00 per annum.
They only need to take $100,000,000.00 in revenue and they are looking at 10cents a share.With a PE of 10 that gives them $1.00 per share.

If they get just 1% of the overall market that gives them access to revenues of $5billion.
If there cut is just 7% of that gives them $350,000,000.00.
After tax that is earnings of around $25cents per share.At a PE of 12 that gives them $3.00 a share.

Extrapolate and we have the very next Cochlear.Dont discount $20.00 a share.